- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
21 CFR Part 11: Where Are We Now?
November 1, 2003
William Goebel
Pharmaceutical Technology, Pharmaceutical Technology-11-01-2003, Volume 2003 Supplement, Issue 5
FDA's revised guidance on 21 CFR Part 11 offers relief to the regulated industry by providing for enforcement discretion and suggesting a risk-based approach to compliance.